Literature DB >> 2410726

Role of vascular alpha 2-adrenoceptors as targets for circulating catecholamines in the maintenance of blood pressure in anaesthetised spontaneously hypertensive rats.

R Sawyer, P Warnock, J R Docherty.   

Abstract

We examined the blood pressure-lowering effects of the alpha 2-adrenoceptor antagonist rauwolscine in anaesthetised spontaneously hypertensive rats (SHR). In the absence of prior drug, rauwolscine (1-10 mg kg-1) produced dose-dependent falls in diastolic blood pressure (DBP). In the presence of prazosin (1 mg kg-1) to eliminate alpha 1-adrenoceptor-mediated responses, rauwolscine (0.1-1 mg kg-1) lowered DBP in unoperated and sham-operated animals but not in adrenal demedullated animals. Hence, we were able to demonstrate that alpha 2-adrenoceptors are involved in the control of blood pressure in intact anaesthetised SHR but not following adrenal demedullation, suggesting that circulating catecholamines are responsible for these alpha 2-adrenoceptor-mediated pressor effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410726     DOI: 10.1097/00005344-198507000-00029

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.

Authors:  Rodney A Velliquette; Rachel Kossover; Stephen F Previs; Paul Ernsberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-01-17       Impact factor: 3.000

2.  Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogs.

Authors:  J P Hieble; A J Nichols; T A Fredrickson; P D DePalma; R R Ruffolo; D P Brooks
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

3.  Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.

Authors:  S M Gardiner; T Bennett
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.